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Over the last decade, polymer micelles attracted an increasing interest in drug pharmaceutical 
research because they could be used as efficient drug delivery systems1,2. Micelles of amphiphilic 
block copolymers are supramolecular core-shell type assemblies of tens of nanometers in diameter3.  
 
In principle, the micelles core is usually constructed with biodegradable hydrophobic polymers 
such as aliphatic polyesters, e.g. poly(ε-caprolactone) (PCL), which serves as a reservoir for the 
incorporation of various lipophilic drugs. Water soluble poly(ethylene oxide) (PEO) is most frequently 
used to build the micelle corona because it is very efficient in preventing protein adsorption at surfaces 
and in stabilizing the micelles in the blood compartment, giving rise to particles invisible to the body 
defence system (so-called stealthy or long circulating particles). Improvements of such simple systems 
however, rely on the development of novel chemistries and materials by advanced macromolecular 
engineering techniques4. 
 
The tumour targeting of a cytotoxic agent refers to the passive accumulation of polymer 
nanocarriers to solid tumours (EPR effect) followed by active internalization in tumor cells. The 
internalization of the drug is required for cell death because most cytotoxic drugs act intracellularly. 
Accordingly, polymer micelles are usually modified by specific ligands. However, these ligands can 
decrease the micelles stealthiness and stability. No-specific ligands can be used if their exposition is 
modulated by the pH decrease typical of tumour tissues. 
 
Lipophilic drugs are generally incorporated in the hydrophobic core of the micelles. The release 
of the drug is ruled by diffusion and degradation of the biodegradable polymer used as reservoir. Even 
if micelles get a high stability in aqueous media thanks to their low critical micellar concentration, the 
dissociation of micelles is not always preserved when they are injected in the blood compartment. The 
cross-linking of the core of micelles by disulfide bridges will provide the stability of micelles after the 
administration and will release the drugs intracellularly by enzymatic breaking of disulfide bridges.  
 
This work consists in the development of new macromolecular architectures for the targeting of 
tumour cells. pH sensitive copolymers able to micellize so as non-specific ligand like biotin is exposed 
on their surface in response to pH decrease typical for tumour tissues (scheme) will be synthesized by 
the incorporation of pH-sensitive linkers like hydrazone or imine benzoïc linkers. In addition, the core 
of these new micelles will be cross-linked by disulfide bridges to prevent dissociation around healthy 
cells and trigger the drug release inside tumour cells.  
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